Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Lymphocytic Neoplasm — Research · CancerIndex

Cancers
Neoplasm
Neoplasm by Morphology
Hematopoietic and Lymphoid Cell Neoplasm
Lymphocytic Neoplasm

Cancer Family

Lymphocytic Neoplasm

CI-CAN-00000223Explore in graph →

HematologicNon-malignant3,037 active trials72 approved drugs345 evidence items

NCIt: C7065

Overview
Statistics
Survival
Genomics38
Variants & evidence345
Drugs51
Trials12948
Research
Rankings
Sources & provenance

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Trials tab
Methodology: publication counts

Literature

Linked publications (351)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedProvenance

Source: PubMed (NLM)
Dataset: PubMed E-utilities
Retrieved: Sep 8, 2026
Layer: normalized (units and labels harmonized; values unchanged)

PublishedShowing 326–350 of 351 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Heterogeneity in therapeutic response of genetically altered myeloma cell lines to interleukin 6, dexamethasone, doxorubicin, and melphalan.
· Blood · 2000 · PMID 11050000 · validated civic_curation pubmed
Oncogenic RAS mutations in myeloma cells selectively induce cox-2 expression, which participates in enhanced adhesion to fibronectin and chemoresistance.
· Blood · 2006 · PMID 16497971 · validated civic_curation pubmed
Episomal amplification of NUP214-ABL1 fusion gene in B-cell acute lymphoblastic leukemia.
· Blood · 2012 · PMID 23175662 · validated civic_curation pubmed
Mantle cell lymphoma cells express predominantly cyclin D1a isoform and are highly sensitive to selective inhibition of CDK4 kinase activity.
· Blood · 2006 · PMID 16690963 · validated civic_curation pubmed
MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.
· N Engl J Med · 2012 · PMID 22931316 · validated civic_curation pubmed
Antimyeloma activity of bromodomain inhibitors on the human myeloma cell line U266 by downregulation of MYCL.
· Anticancer Drugs · 2016 · PMID 27276402 · validated civic_curation pubmed
The preleukemic TCF3-PBX1 gene fusion can be generated in utero and is present in ≈0.6% of healthy newborns.
· Blood · 2019 · PMID 31434706 · validated civic_curation

Showing 326–350 of 351 publications

← Previous
1
…
13
14
15
Next →

Andersson et al. Nat Genet 2015

· 2015 · PMID 25730765 · validated cbioportal_study pubmed

Maura, Francesco et al. Blood cancer discovery 2023

· 2023 · PMID 36723991 · validated cbioportal_study pubmed

Landau et al. Nature 2015

· 2015 · PMID 26466571 · validated cbioportal_study pubmed

Knisbacher et al. Nature 2022

· 2022 · PMID 35927489 · validated cbioportal_study pubmed

Puente et al. Nature 2015

· 2015 · PMID 26200345 · validated cbioportal_study pubmed

Quesada et al. Nature Genetics 2011

· 2011 · PMID 22158541 · validated cbioportal_study pubmed

Da Silva Almeida et al. Nat Genet 2015

· 2015 · PMID 26551667 · validated cbioportal_study pubmed

Lohr et al. PNAS 2012

· 2012 · PMID 22343534 · validated cbioportal_study pubmed

Chapuy et al. Nat Med 2018

· 2018 · PMID 29713087 · validated cbioportal_study pubmed

Reddy et al. Cell 2017

· 2017 · PMID 28985567 · validated cbioportal_study pubmed

Landau et al. Cell 2013

· 2013 · PMID 23415222 · validated cbioportal_study pubmed

Zhu, Meng-Lei et al. Haematologica 2024

· 2024 · PMID 38497151 · validated cbioportal_study pubmed

Thomas et al. Blood 2023

· 2023 · PMID 36201743 · validated cbioportal_study pubmed

BeÃ et al. PNAS 2013

· 2013 · PMID 24145436 · validated cbioportal_study pubmed

Lohr et al. Cancer Cell 2014

· 2014 · PMID 24434212 · validated cbioportal_study pubmed

William T et al. Blood Adv 2023

· 2023 · PMID 37078708 · validated cbioportal_study pubmed

Morin et al. Blood 2013

· 2013 · PMID 23699601 · validated cbioportal_study pubmed

Braggio et al. Clin Cancer Res 2015

· 2015 · PMID 25991819 · validated cbioportal_study pubmed